← Leaderboards
Matthew John Atherton
University Of Pennsylvania
$768,255
Attributed
$768,255
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $153.7K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$768,255 · 1
By mechanism
K08$768,255 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Serge Y Fuchs$17,647,204
- Daniel Patrick Kelly$33,087,106
- James L Riley$56,591,102
- Luca Busino$6,731,473
- Meenhard Herlyn$50,214,821
Others in their field
Other Emerging Leaders on “Adoptive Cell Transfers”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Bronwen Shaw · Medical College Of Wisconsin$10,707,191
- Christopher M Jewell · Baltimore Va Medical Center$4,659,871
- Michael Daniel Keller · Children'S Research Institute$4,383,748
- Raiees Ahmad Andrabi · Scripps Research Institute, The$4,211,839
- Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh$4,078,539
Research focus
Adoptive Cell TransfersAnti-Tumor Immune ResponseAutologousAntigensB-Cell LymphomasB-Cell NeoplasmBiologicalBlood Component RemovalAwardB-LymphocytesB Lymphoid MalignancyCancer PatientCancer TherapyCanis FamiliarisCareer DevelopmentCd19 GeneCell CountCellsBlood ProductCell SurfaceCell TherapyCessation Of LifeChimeric AntibodyChronic Lymphocytic Leukemia
Grant awards (5)
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer$153,651
K08 · FY2025 · CA · contact PI
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer$153,651
K08 · FY2024 · CA · contact PI
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer$153,651
K08 · FY2023 · CA · contact PI
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer$153,651
K08 · FY2022 · CA · contact PI
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer$153,651
K08 · FY2021 · CA · contact PI